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KESAN SUPLEMEN MADU TUALANG KE ATAS STATUS STRES 
OKSIDATIF, KERADANGAN DAN PROFIL LIPID DALAM KALANGAN 
PEROKOK KRONIK 
 
ABSTRAK 
 
 Peningkatan stres oksidatif, keradangan dan perubahan dalam profil lipid 
perokok telah dikaitkan sebagai faktor utama kaitan merokok dengan penyakit 
kardiovaskular. Walaubagaimanapun, kesan kebaikan madu sebagai antioksidan, 
antiradang dan antilipid dalam kalangan perokok masih belum dilaporkan. Oleh itu, 
kajian ini adalah untuk menentukan faedah suplemen Madu Tualang ke atas stres 
oksidatif, keradangan dan profil lipid dalam kalangan perokok. Seramai 36 bukan 
perokok dan 72 perokok telah dipilih. Kumpulan perokok kemudiannya dibahagikan 
secara rawak kepada dua kumpulan iaitu perokok tanpa suplemen dan perokok dengan 
suplemen madu sebanyak 20 gram setiap hari selama 12 minggu. Sampel darah telah 
diperolehi bagi menentukan tahap stres oksidatif, keradangan dan profil lipid daripada 
semua kumpulan di peringkat pra-intervensi dan daripada kumpulan perokok di 
peringkat pos-intervensi. Pada peringkat pra-intervensi, perokok secara signifikan 
mempunyai nilai F2-isoprostanes, jumlah status antioksidan (TAS) dan katalase (CAT) 
yang lebih tinggi berbanding dengan bukan perokok. Aktiviti superoksida dismutase 
(SOD) dan glutation peroksidase (GPx) secara signifikan adalah lebih rendah dalam 
kalangan perokok berbanding dengan bukan perokok. Nilai tahap sensitiviti protein C-
reaktif (hsCRP) secara signifikan adalah lebih tinggi dalam kalangan perokok 
xx 
 
berbanding dengan bukan perokok. Walaubagaimanapun, tiada perbezaan yang 
signifikan ditunjukkan dalam nilai factor tumor necrosis alfa (TNF-α) dan interleukin-6 
(IL-6). Selain itu, perokok pada peringkat pra-intervensi menunjukkan secara signifikan 
tahap yang lebih rendah bagi nilai lipoprotein ketumpatan tinggi (HDL) dan tahap yang 
lebih tinggi bagi jumlah kolesterol (TC), lipoprotein ketumpatan rendah (LDL) dan 
trigliserida (TG) berbanding dengan bukan perokok. Dalam kalangan perokok, Madu 
Tualang secara signifikan menurunkan nilai F2-isoprostanes dan juga meningkatkan 
nilai/aktiviti TAS, CAT, dan GPx.  Madu Tualang juga secara signifikan meningkatkan 
nilai TNF-α dan menurunkan nilai hsCRP. Selain itu, Madu Tualang secara signifikan 
menurunkan nilai TC dan LDL. Penemuan ini mencadangkan faedah Madu Tualang 
terhadap stress oksidatif, keradangan dan juga perubahan dalam profil lipid dalam 
kalangan perokok yang mungkin boleh mengurangkan pembentukan ateroma dan 
seterusnya risiko penyakit jantung. Sebahagian daripada kesan ini boleh dikaitkan 
dengan kepelbagaian komponen Madu Tualang termasuklah asid fenolik dan sebatian 
flavonoid yang memiliki sifat antioksidan, antiradang dan antilipid. Namun, kajian lebih 
lanjut diperlukan untuk menjelaskan kesan mekanisme yang tepat ke atas faedah Madu 
Tualang.  
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EFFECTS OF TUALANG HONEY SUPPLEMENTATION ON OXIDATIVE 
STRESS STATUS, INFLAMMATION AND LIPID PROFILES IN CHRONIC 
SMOKERS 
 
ABSTRACT 
 
 Elevated oxidative stress, inflammation and alteration in lipid profiles in smokers 
have been proposed as among the major factors that contribute to the development of 
smoking-related cardiovascular disease. However, the possible beneficial effect of 
Tualang honey that has antioxidant, anti-inflammatory and antilipid properties among 
smokers has yet been reported. The aims of this study, therefore, to determine the effects 
of Tualang Honey supplementation on oxidative stress markers, inflammatory markers 
and lipid profiles in smokers. A total of 36 non smokers and 72 smokers were recruited. 
The smokers were then randomly divided into 2 groups namely smokers without 
supplementation and smokers with honey supplementation at the dose of 20 gram/day 
for 12 weeks. Blood was obtained for determination of oxidative stress markers, 
inflammatory markers and lipid profiles from all groups at pre-intervention and from 
smokers group at post-intervention. At pre-intervention, smokers had significantly 
higher levels of F2-isoprostanes, total antioxidant status (TAS) and catalase (CAT) 
activity compared to non smokers. Meanwhile, the activities of superoxide dismutase 
(SOD) and glutathione peroxidase (GPx) were significantly lower in smokers than non 
smokers. A significantly higher level of high sensitivity C-reactive protein (hsCRP) was 
xxii 
 
found in smokers compared to non smokers. However, no significant differences were 
found for the levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). 
Furthermore, significantly lower high-density lipoprotein (HDL) as well as higher total 
cholesterol (TC), low-density lipoprotein (LDL) and triglyceride (TG) levels were 
observed in smokers compared to non smokers. In smokers, Tualang honey 
supplementation significantly decreased the level of F2-isoprostanes as well as increased 
the levels/activities of TAS, CAT and GPx. Tualang honey also significantly increased 
the level of TNF-α and decreased the level of hsCRP. Apart from that, Tualang honey 
significantly decreased the levels of TC and LDL. These observations might suggest a 
beneficial effect of Tualang honey against cigarette smoke-induced oxidative stress, 
inflammation as well as alteration in lipid profiles among smokers which may provide 
an effect in reducing the atherothrombosis formation and subsequent risk of 
cardiovascular disease. These beneficial effects could be, partly attributed to its various 
components which include phenolic acids and flavonoid compounds that have 
antioxidant, anti-inflammatory and antilipid properties. However, further studies are 
required to elucidate the exact mechanism of action on these benefical effects of Tualang 
honey
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CHAPTER 1 
INTRODUCTION 
Cigarette smoking has been reported as one of the major risk factor for the 
development of cardiovascular diseases. The other factors include hypertension, 
coronary artery disease, atherosclerotic vascular disease, myocardial infarct and stroke 
(Ockene and Miller, 1997). The related major factors in initiating and accelerating the 
atherothrombotic process which contribute to the development of cardiovascular disease 
are oxidant-antioxidant imbalance, inflammation, alteration in lipid profiles as well as 
endothelial dysfunction.  
 
 Several studies reported that cigarette smoke (CS) exposure is associated 
with increased lipid peroxidation (Garg et al., 2006; Bloomer, 2007; Pasupathi et al., 
2009), an alteration in the levels of erythrocyte antioxidant enzymes, (Pannuru et al., 
2011; Tonguc et al., 2011; Aziz et al., 2013), decreased total antioxidant status (TAS) 
(Bloomer, 2007; Jha et al., 2007; Aziz et al., 2013), increased levels of serum 
inflammatory markers such as tumor necrosis factor-α (TNF-α) and C-reactive protein 
(CRP) (Petrescu et al., 2010) as well as decreased level of plasma antioxidant such as 
ascorbic acid, the reduced form of vitamin C (Ayaori et al., 2000). In addition, as 
smoking is associated with increased lipolysis, it has been reported that the levels of 
total cholesterol (TC), low density lipoprotein (LDL) and triglycerides (TG) are
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significantly higher while the level of high density lipoprotein (HDL) is 
significantly lower in smokers compared to non smokers (Rao and Emmanuel, 2012). 
 Although quit smoking is the best method to reduce the risk of cardiovascular 
diseases, there is still a need to reduce this risk among chronic smokers who fail to quit 
smoking by any means. This has led to increased interest to investigate the possible 
beneficial effect of natural products in reducing this risk among smokers. A study has 
reported that 6-week supplementation of green algae namely Chlorella vulgaris, which 
has antioxidant activity, among smokers significantly increases the levels of erythrocyte 
antioxidant enzymes activities such as catalase (CAT) and superoxide dismutase (SOD). 
The levels of plasma antioxidants such as vitamin C and α-tocopherol are also 
significantly increased (Lee et al., 2010). Meanwhile, Leelarungrayub and colleague 
have observed that 8-week supplementation of another herb namely Vernonia cinerea 
Less among active smokers significantly decreases malonaldehyde (MDA) level and 
increases TAS (Leelarungrayub et al., 2010). Apart from that, supplementation of camu-
camu juice (with high vitamin C content), which has anti-inflammatory activity, among 
male smokers for 7 days significantly reduces the levels of serum high sensitivity C-
reactive protein (hsCRP), interleukin-6 (IL-6) and interleukin-8 (IL-8) (Inoue et al., 
2008). Meanwhile, 2-month supplementation of vitamin C significantly reduces the 
levels of plasma F2-isoprostanes as well as C-reactive protein (CRP) in passive smokers 
(Dietrich et al., 2003). In addition, supplementation of vitamin C-rich fruit juices for 26 
days (Alvarez-Parrilla et al., 2010) as well as Quercitin-rich supplement for 10 weeks 
(Lee et al., 2011) significantly decreases TC and LDL levels in smokers. 
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 Honey is a natural product of bees produced from nectar of blossoms and 
honeydew. The honeydew is formed from plant-sucking insects or secretions of plants 
(Alimentarius, 2001). The flavour, colour and contents of honey vary depending on 
botanical origin of honey (Oddo et al., 2004). The primary contents of honey are 
carbohydrates such as fructose and glucose as well as organic acids, proteins, minerals 
and aromatic compounds (Bogdanov et al., 2008). Apart from that, honey also contains 
antioxidants such as vitamins A and E (Al-Waili, 2003), enzymes such as glucose 
oxidase and catalase (Gheldof et al., 2002), phenolic acids (Michalkiewicz et al., 2008; 
Pyrzynska and Biesaga, 2009), flavonoids (Yao et al., 2004; Khalil et al., 2011a), as 
well as has antioxidant properties (Mohamed  et al., 2010a). 
 
 Earlier studies have reported the effectiveness of honey in treating wounds, 
burns, ulcers and other inflammatory diseases in both human (Cavanagh et al., 1970; 
Blomfield, 1973; Zumla and Lulat, 1989; Subrahmanyam, 1991; Pieper, 2009) and 
animal subjects (Bergman et al., 1983; Oryan and Zaker, 1998). Meanwhile, scientific 
studies have demonstrated that honey possesses numerous important biological 
properties which include antioxidant (Beretta et al., 2005; Perez et al., 2006; Korkmaz 
and Kolankaya, 2009; Mohamed  et al., 2010a; Tartibian et al., 2011), anti-inflammatory 
(Prakash et al., 2008; Bashkaran et al., 2011; Tartibian et al., 2011; Ahmad et al., 2012; 
Mohd Effendy et al., 2012), immunomodulatory (Timm et al., 2008), antimicrobial 
(Molan, 2006; Tan et al., 2009; Khoo et al., 2010; Al-Waili et al., 2011; Sukur et al., 
2011) and anticancer properties (Swellam et al., 2003; Ghashm et al., 2010). In addition, 
supplementation of honey in rats exposed to CS for 13 weeks has been reported to 
improve testicular functions (Mahaneem et al., 2011) as well as to reduce damage and 
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oxidative stress in the testis partly by reducing lipid peroxidation and restoring 
antioxidant system (Mohamed et al., 2010b). 
 
 However, to date, no study has been reported to determine whether honey 
supplementation is able to protect against oxidative stress and inflammation as well as to 
improve lipid profiles among chronic smokers. Therefore, the aim of this study was to 
determine the possible role of honey in protecting against or reducing the oxidative 
stress and inflammation as well as in improving the lipid profiles among chronic 
smokers.  
 The specific objectives of this study were: 
1) To determine the effects of honey supplementation on oxidative stress markers 
such as plasma F2-isoprostanes, erythrocyte antioxidant enzymes [SOD, 
glutathione peroxidase (GPx), CAT] and TAS in chronic smokers. 
2) To determine the effects of honey supplementation on the levels of plasma 
inflammatory markers such as IL-6, hsCRP and TNF-α in chronic smokers. 
3) To determine the effects of honey on serum fasting lipid profiles such as TC, 
LDL, HDL and TG in chronic smokers. 
The hypotheses of this study were: 
1) Honey supplementation significantly reduces lipid peroxidation, improves 
erythrocyte antioxidant enzymes as well as improves TAS in chronic smokers. 
2) Honey supplementation significantly reduces inflammation in chronic smokers. 
3) Honey supplementation significantly improves lipid profiles in chronic smokers. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1. An overview on cigarette smoke 
 CS can be divided into 2 phases namely tar phase and gas phase. The tar or 
particulate phase of CS which contains >1017 free radicals/gram, is the material that is 
trapped when the smoke stream is passed through the Cambridge glass-fiber filter that 
retains 99.9% of all particulate material with a size of >0.1 µm. This phase contributes to 
most of the tobacco-associated carcinogenicity. Meanwhile, the gas phase which 
contains >1015 free radicals/puff is the material that passes through the filter (Pryor and 
Stone, 1993).  
 
 CS can also be further categorized into mainstream smoke, sidestream smoke, 
environmental tobacco smoke and third hand smoke. Mainstream smoke (MS) is defined 
as smoke generated at a burning cigarette’s tip when the smoker puffs. It is deeply 
inhaled by the active smoker and comprises 8% of tar and 92% of gaseous component 
(Pryor and Stone, 1993; Nelson, 2001). Sidestream smoke (SS) is defined as the smoke 
emitted from the burning ends of a cigarette and it contains a relatively higher 
concentration of the toxic gaseous component compared to MS (Glantz and Parmley, 
1991). As the production of SS is at lower temperature compared to MS, most of 
carcinogens and toxicants are produced in greater amounts in SS than in MS. The 
particle size for SS is 0.01-1.0 μm while the particle size for MS is 0.1-1.0 μm. This 
discrepancy has implications for the particles to deposit in the various regions of the 
human respiratory tract. In addition, compared to MS, SS has 2–6 times more 
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condensate per gram (Swan and Lessov-Schlaggar, 2007; Bernert et al., 2010) and the 
smokers may be exposed to higher concentrations of carcinogens as a result of 
incomplete combustion process. Meanwhile, environmental tobacco smoke results from 
the mixture of SS (85%) and a small fraction of exhaled MS (15%) which may be 
inhaled by non smoker in a closed or open environment (Taylor et al., 1992).  
 
 On the other hand, third hand smoke (THS) is defined as contamination of 
residual tobacco that remains after the cigarette is extinguished (Winickoff et al., 2009). 
THS includes the residual tobacco smoke pollutants that either (i) persist in dust and on 
surfaces after tobacco has been smoked, (ii) are re-radiate back into the gas phase, or 
(iii) react with oxidants as well as other compounds in the environment forming 
secondary pollutants (Matt, 2011). Exposure to THS is the outcome from the involuntary 
inhalation, dermal uptake or ingestion of THS pollutants in the dust, air and on surfaces. 
In the form of particulate matter, these THS pollutants are accumulated in a layer onto 
every surface within the house in loose household dust. Apart from that, these toxins 
also take the form of volatile toxic compounds that ‘off gas’ into the air over days, 
weeks and months. Therefore, one day of smoking indoor may lead to THS pollutant 
exposure to people within that space in the future (Singer et al., 2002; Matt et al., 2004).  
 
 CS contains about 5,000 chemicals (Borgerding and Klus, 2005; Thielen et al., 
2008) produced following burning of tobacco leaves. The hazardous chemicals present 
in CS include nicotine, tar, carbon monoxide (CO), cadmium, ammonia, benzene, and 4-
aminobiphenyl (Swan and Lessov-Schlaggar, 2007; Bernert et al., 2010). Other 
compounds are hydrogen cyanide, arsenic, vinyl chloride, acrolein, formaldehyde, 
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acetaldehyde, catechol, cresol, hydroquinone, lead, methylethyl, nitricoxide, phenol, 
styrene, tolutene and butane. 
 
CS is a major risk factor for the development of cardiovascular diseases such as 
atherosclerotic vascular disease, hypertension, coronary artery disease, myocardial 
infarct and stroke (Ockene and Miller, 1997). Endothelial dysfunction, inflammation, 
oxidant-antioxidant imbalance or increased lipid peroxidation, activation of leucocytes 
and platelets as well as an alteration of antithrombotic and prothrombotic factors are 
among the smoking related major determinants of initiation and acceleration of the 
atherothrombotic process leading to these cardiovascular diseases. By year 2025, 10 
million smokers are expected to die each year if current trends continue (Davis et al., 
2007; Hatsukami et al., 2008). In addition, according to World Health Organization, 
there are estimated 5.4 million premature deaths caused by tobacco smoking worldwide 
(Organization, 2008). 
 
2.2 Oxidative stress  
 Oxidative stress is a result from imbalance between free radicals species 
production and the antioxidant system in cells (Smith et al., 2005). Oxidative stress 
occurs when there is diminished detoxification or excessive production of free radical 
species. Prolonged highly oxidized cells predispose the surrounding cells to oxidative 
damage (Halliwell, 2007). 
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 Free radicals are defined as atoms and molecules with unpaired electrons in their 
orbital or outer shell (Guetens et al., 2002; Penna et al., 2009). The common property is 
the presence of unpaired electron shared by most radicals. Most of the radicals are 
highly reactive and may either extract or donate an electron from other molecules, thus, 
behaving as reductants or oxidants. A free radical is easily formed when there is broken 
in a covalent bond between entities and one electron remains with each newly formed 
atom. These newly formed free radicals are very unstable, highly reactive and only may 
become stable once they acquire electrons from protein, lipids, carbohydrates, nucleic 
acids and other nearby molecules which therefore, leading to a cascade of damage and 
disease (Da Silva et al., 2010).  
 
 Free radicals may react with lipids, carbohydrates, proteins and DNAs causing 
cellular damage. High level of cellular damage may result in cell death through necrosis 
or apoptosis (Marnett et al., 2003). Lipid peroxidation is due to reaction of free radicals 
on lipids. For example, hydroxyl radical which is a free radical may act as initiator by 
extracting a hydrogen atom, preferably from the double bond of a polyunsaturated fatty 
acid in a lipid membrane. The chain reaction is then propagated forming lipid peroxyl 
radicals and lipid peroxides. This may lead to degradation of lipid forming products such 
as F2-isoprostanes, malondialdehyde (MDA), 4-hydroxynoneal and acrolein. 
 
 F2-isoprostanes are prostaglandin F2-like compounds, produced in vivo, primarily 
in situ, by nonenzymatic free-radical–catalyzed peroxidation of esterified arachidonic 
acid (Lynch et al., 1994). It is then cleaved by phospholipase before being released into 
the circulation. Finally, it is excreted in the urine as free isoprostanes. The plasma levels 
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of F2-isoprostanes have been shown as an indicator of in vivo oxidative stress (Lynch et 
al., 1994).  In human, F2-isoprostanes are present in two forms, either esterified to lipids 
which is being the most abundant and or as free F2-isoprostanes (Dalle-Donne et al., 
2006). Previous study reported that measurement of F2-isoprostanes is a reliable 
indicator of oxidative stress in vivo due to several factors: (i) F2-isoprostanes are stable 
compounds (ii) specific lipid peroxidation products (iii) formation of F2-isoprostanes 
increases dramatically in vivo in number of animal models of oxidant injury (iv) levels 
of F2-isoprostanes are not affected by lipid content of the diet (v) formation of F2-
isoprostanes is modulated by antioxidant status (vi) F2-isoprostanes levels are present in 
detectable quantities in all normal biological tissues and fluids, thus, allowing the 
definition of a normal range (Roberts II and Morrow, 2000). In addition, another study 
observed that F2-isoprostanes is the ‘gold standard’ and very specific compared to other 
lipid peroxidation assays (Hollman et al., 2011).  
 
 On the other hand, nitrosative stress is due to reaction between reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) in damaging the cells. ROS originate 
from oxygen while RNS originate from the reaction of oxygen with nitrogen. ROS and 
RNS are collective terms that include both radicals as well as non radicals that are 
oxidizing agents and/or easily converted into radicals. Example of ROS and RNS are 
shown in Table 2.1.  
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2.2.1  Reactive Oxygen Species (ROS) 
Primary ROS are the superoxide anion either arising following oxygen 
‘activation’ by physical irradiation or through metabolic processes. The secondary ROS 
are formed when the primary ROS further interact with other molecules either directly or 
prevalently through enzyme- or meta-catalyzed processes (Valko et al., 2005). 
Formation of superoxide anion is by univalent reduction of triplet-state molecular 
oxygen (3O2) (Droge, 2002). It is mediated by the enzymes such as xanthine oxidase and 
NAD(P)H oxidase or nonenzymically by redox-reactive compounds which include 
semiubiquinone compound of the mitochondrial electron transport chain (Droge, 2002). 
Production of superoxide anion occurs mostly within the cell of mitochondria (Cadenas 
and Sies, 1998). Conversion of superoxide anion to hydrogen peroxide (H2O2) is by 
SOD (Deby and Goutier, 1990). Nonenzymically, superoxide anion is converted to 
nonradical species H2O2 and singlet oxygen (1O2) (Steinbeck et al., 1993). H2O2 is 
converted to hydroxyl radical (.OH) which is highly reactive with reduced transition 
metals such as copper or ferrous ions (Chance et al., 1979). Consumption of oxygen in 
the peroxisome leads to production of H2O2, which is then used to oxidize a variety of 
molecules (Valko et al., 2007).  
 
2.2.2  Reactive Nitrogen Species (RNS) 
 Production of nitric oxide radical is by oxidation of one terminal guanido-
nitrogen atoms of L-arginine catalyzed by nitric oxide synthase (Palmer et al., 1988). 
Meanwhile, nitric oxide can be converted into various RNS namely nitronium cation 
(NO2+) and peroxynitrate (ONOO-).  
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Table 2.1: Examples of ROS and RNS.  
Types ROS RNS 
 
 
Radicals  
 
Superoxide (O2.-) 
Hydroxyl (OH.) 
Peroxyl (RO2.) 
Hydroperoxyl (HO2.) 
Alkoxyl (RO.) 
 
 
Nitric oxide (NO.) 
Nitrogen dioxide (NO2.) 
 
Nonradicals  
 
Hydrogen peroxide (H2O2) 
Hypochlorous acid  (HOCL) 
Singlet oxygen (1O2) 
Ozone (O3) 
 
Nitrous acid (HNO2) 
Dinitrogen trioxide (N2O3) 
Dinitrogen tetroxide (N2O4) 
Peroxynitrite (ONOO-) 
Peroxynitrous acid (ONOOH) 
Nitronium cation (NO2+) 
Alkyl peroxynitrites (ROONO) 
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2.2.3 Antioxidant defense system 
 Antioxidants that protect the cells against the oxidative damage by free radicals 
can be divided into two groups namely enzymatic antioxidants and non-enzymatic 
antioxidants. The enzymatic antioxidants include SOD, CAT, GPx, glutathione 
reductase (GR) (Smith et al., 2005) as well as glutathione S-transferase (GST) (Hayes et 
al., 2005). Meanwhile, the non-enzymatic antioxidants are glutathione, vitamin C 
(ascorbic acid), vitamin E (α-tocopherol), flavonoids (Smith et al., 2005) and metal 
binding proteins such as ceruloplasmin and transferrin (Halliwell and Gutteridge, 1990). 
Enzymatic antioxidants convert ROS or free radicals into non-toxic products while non-
enzymatic antioxidants terminate free radical chain reactions and prevent free radicals 
formation (Smith et al., 2005). 
 
(a) Enzymatic antioxidants 
 Three major antioxidant enzymes that have significant roles in protecting cells 
from oxidants are SOD, CAT and GPx (Bowen, 2003).  
 
i. Superoxide dismutase 
 SOD is present in every cell in the body (endogenously produced antioxidant 
enzyme). There are three SOD isoforms in human which include: copper zinc-containing 
SOD (Cu/Zn-SOD), manganese-containing SOD (Mn-SOD) and extracellular Copper-
zinc containing SOD (EC-SOD). Cu/Zn-SOD is rich in cytoplasm, nucleus and 
peroxisomes. Cu/Zn-SOD plays an important role in the first line of antioxidant defense 
system as it contributes most of the total activity of SOD (McCord and Fridovich, 1969). 
Meanwhile, Mn-SOD is abundantly found in mitochondria but very minimal in 
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cytoplasm. Within the mitochondria, its central role is catalyzing superoxide anions. On 
the other hand, EC-SOD is produced by fibroblast, vascular smooth muscle and glial cell 
and secreted into extracellular space. EC-SOD functions as plasma protein and thus, a 
protector in the extracellular space. 
 
 Role of SOD is to protect harmful effects of superoxide free radical against 
oxygen-metabolizing cells. It is involved in catalyzing the dismutation of superoxide to 
H2O2 and oxygen. However, in decomposing the H2O2, SOD must work in conjunction 
with other enzymes which include GPx and CAT. If H2O2 is left unchallenged, it may 
unite with iron or copper ions forming a very reactive hydroxyl radical. 
 
ii. Catalase 
 CAT is widely distributed in the cell. Majority of CAT activity occurs in the 
peroxisomes and mitochondria (Kirkman and Gaetani, 1984). CAT catalyzes the 
decomposition of H2O2 to water and oxygen molecules (Mates et al., 1999). Of all the 
enzymes, CAT has one of the highest turnover rates as one molecule of CAT is able to 
convert millions molecules of H2O2 to water and oxygen per second (Switala and 
Loewen, 2002). Removal of H2O2 indirectly detoxifies superoxide radicals which have 
been converted into H2O2 by the action of SOD. CAT is an intracellular antioxidant 
enzymes mainly present in cellular peroxisomes and to some extent in the intracellular 
granules and cytosol (Young and Woodside, 2001). Therefore, CAT mainly catalyzes 
the decomposition of H2O2 produced within the peroxisomes. The high level of CAT in 
these organelles may prevent toxic compounds accumulation. On the other hand, when 
the level of CAT is insufficient, H2O2 produced within the peroxisomes will be delivered 
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into the cytosol which subsequently predisposed to oxidative stress (Kirkman and 
Gaetani, 1984).  
 
iii. Glutathione peroxidase 
 Six different isoforms of GPx protein have been identified which referred to 
GPx1 to GPx6. GPx requires selenium at the active site for its catalytic activity. GPx 
activity is dependent on the constant GSH availability. GPx involves in catalyzing the 
reduction of H2O2 to water as well as the oxidation of reduced glutathione (GSH) to 
oxidized glutathione (GSSG) (Forstrom et al., 1978).  
 
(b) Non-enzymatic antioxidants 
Non-enzymatic antioxidants can be further divided into two categories which include 
chain breaking antioxidants and transition metal binding proteins. 
 
i. Chain breaking antioxidants 
 Chain breaking antioxidants can be classified into lipid phase and aqueous phase 
antioxidants. The most common lipid phase antioxidants include flavonoids, Vitamin E, 
carotenoids and ubiquinol-10 while the most common aqueous phase are vitamin C and 
protein bound thiols group such as thioreduxin and glutathione (Powers et al., 2004). 
When there is an interaction between two molecules of free radicals, this may lead to 
generation of secondary molecule of radicals and subsequently, this molecule may react 
with other targets to produce more radical species. The reaction may continue until the 
radicals are neutralized by a chain breaking antioxidants or two radicals may combine to 
form stable products (Young and Woodside, 2001).  
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 Flavonoids which are one of phenolic compounds present in the plant-derived 
food have been demonstrated to act as antioxidants. They may (i) inhibit enzymes such 
as xanthine oxidase which is responsible for formation of superoxide anion (ii) prevent 
the involvement of copper and ferrous in the Fenton reaction to form hydroxyl radical by 
chelating these metals and (iii) form a complex with the free radicals to stabilize them by 
donating the electrons to superoxide or lipid peroxyl radicals (Smith et al., 2005). 
 
 Vitamin E such as α-tocopherol is involved in protection against lipid 
peroxidation in the cell membranes. It terminates free radical chain reaction by donating 
an electron to lipid peroxyl radical and then another electron to another lipid peroxyl 
radical. These two steps of reactions may lead to formation of more stable lipid 
peroxides. This is followed by conversion of Vitamin E itself to fully oxidized form. On 
the other hand, vitamin C which circulates unbound in extracellular fluid and blood is a 
water soluble antioxidant. It is also involved in terminating the free radical chain 
reaction by donating electrons to free radicals in two steps reactions and becomes 
oxidized. Apart from that, by donating electrons in a redox cycle, vitamin C may 
regenerate the reduced form of vitamin E (Smith et al., 2005).  
 
  Glutathione (GSH) or γ-L-glutamyl-L-cysteinyl glycine is a water soluble 
tripeptide. It is the most prominent low molecular weight thiol in animal cells. GSH is 
produced within the cell from cysteine, glycine and glutamine and catalyzed by two 
cytosolic enzymes which include GSH synthase and γ-glutamylcysteine synthase (Wu et 
al., 2004). Most of cellular GSH is mainly found in the cytosol (85-90%) while the 
remainder present in the organelles such as peroxisomes, mitochondria and nuclear 
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matrix (Lu, 2009). GSH in cells is utilized by GPx. During glutathione redox cycle, 
oxidized glutathione (GSSG) or glutathione disulfide forms in the mitochondria are 
reduced to GSH by the action of GR or it may accumulate within the mitochondria. 
Therefore, compared to cytosol, GSSG level is found higher in mitochondria. It is 
suggested that the degradation of H2O2 inside the mitochondria is done by GPx and GSH 
(Lu, 2009).  
 
ii. Transition metal binding proteins 
 The most common transition metal binding proteins include transferrin, ferritin, 
ceruloplasmin and lactoferrin. These proteins act as important components of the non-
enzymatic antioxidant by sequestering copper and iron to prevent the occurrence of 
hydroxyl radical formation. The example of copper binding protein is caeruloplasmin 
which acts by catalyzing the oxidation of divalent iron ferrous ion (Fe2+) to form ferric 
ion (Fe3+). The less reactive Fe3+ form resulting from rapid oxidation of Fe2+ is thus an 
antioxidant effect of caeruloplasmin (Young and Woodside, 2001). The actions of these 
enzymatic and non-enzymatic are illustrated in Figure 2.1. 
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Figure 2.1: Actions of enzymatic and non-enzymatic antioxidants: O2, oxygen; SOD, superoxide dismutase; GPx, 
glutathione peroxidase; H2O, water; PUFA, polyunsaturated fatty acid; CAT, catalase; GSH, reduced glutathione; GSSG, 
glutathione disulphide or oxidised glutathione; GR, glutathione reductase; ROS, reactive oxygen species; GST,  glutathione-
S-transferase; NADP+, nicotinamide adenine dinucleotide phosphate; NADPH, reduced form of NADP+.  
[Adapted from Mohamed, M. (2012)]. 
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2.3. Cigarette smoke and oxidative stress  
Although the precise mechanism is not clearly determined, the free radical-
mediated oxidative stress appears to play a major role in smoking-mediated 
cardiovascular diseases (Tanriverdi et al., 2006). CS has been demonstrated to have free 
radicals which include quinone, semiquinone, hydroquinone, nitric oxide as well as 
carbon-centered radicals such as acyl- and alkylaminocarbonyl radicals (Church and 
Pryor, 1985; Bartalis et al., 2009). Quinone, semiquinone, and hydroquinone can be 
oxidized to form superoxide anion which finally form H2O2 and hydroxyl radical. 
Meanwhile, nitric oxide can be oxidized forming nitrogen dioxide (Church and Pryor, 
1985). 
 
 RNS and ROS are produced when there is interaction between mainstream 
smoke with physiological fluids or aqueous media. Some CS components are involved 
in oxidative stress only after they are chemically modified by metabolic process in vivo. 
For example, benzo[a]pyrene can be metabolized via a redox cycling mechanism to its 
corresponding quinone, which may produce ROS (Winston et al., 1993; Briede et al., 
2004).  
 
 Several studies reported that aqueos dimethyl sulfoxide solutions of aqueous 
extract of cigarette tar saturated with air and buffered at pH 9 contain superoxide radical 
anion which is one of the ROS involved in oxidative stress. The suggested mechanism 
for the superoxide formation in aqueous extract of cigarette tar was the autooxidation of 
the hydroquinone anion (and related anions) in air to give superoxide and 
benzosemiquinone radical (Brunmark and Cadenas, 1989; Zang et al., 1995). In 
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addition, another important stress-related ROS hydroxyl radical, is identified in aqueous 
extract of cigarette tar. The suggested mechanism for the hydroxyl radical formation was 
the catalytic disproportionation of H2O2 by transition metal ions, known as Fenton 
reaction (Cosgrove et al., 1985).  
 
 H2O2 is a by-product of oxidative stress. It is formed in living organisms during 
normal respiration by catalytic disproportionation of superoxide radicals by SOD. CAT, 
another enzyme, is efficient at converting H2O2 to water and oxygen. If this cellular 
defense mechanism is overwhelmed, the excess H2O2 may undergo disproportionation 
via Fenton reaction forming hydroxyl radicals. The hydroxyl radicals derived from H2O2 
are well known to cause oxidative damage to essential biomoleculecules including DNA 
and highly oxidixing species (Halliwell and Gutteridge, 1999). H2O2 that forms by the 
physiological response to smoke components and exogenous H2O2 found in cigarette are 
known to be a source of oxidative stress in smokers (Wooten et al., 2006). 
 
 Meanwhile, the toxicity of quinones is reported to occur by two mechanisms 
namely the formation of covalent bonds with essential biological molecules (especially 
molecules containing thiol groups) and the redox cycling mechanisms which generates 
excess ROS as byproducts (Seung et al., 1998; Rodriguez et al., 2004). Both 
mechanisms may lead to the onset of oxidative stress. Quinones derived from CS 
components undergo redox cycling by entering into the NADPH reductase pathway in 
living organisms (Squadrito et al., 2001; Hirakawa et al., 2002). The reduction of 
quinones by ascorbate or NADPH may contribute to generation of the parent quinols, 
thus creating the redox cycle. Redox cycling of xenobiotic quinones may significantly 
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increase the cellular burden of ROS as well as deplete their antioxidant defences 
(Roginsky et al., 1999). 
 
 In CS, redox inactive metals such as lead, cadmium, arsenic and mercury may 
deplete cells of thiol-containing antioxidants and reduce the activity of antioxidant 
enzymes. Meanwhile, redox active metals such as iron, copper, nickel and chromium 
may undergo redox cycling with concomitant ROS formation in oxygenated aqueous 
solutions. Heavy metals may exert other molecular effects such as activation of cellular 
signalling and inhibition of DNA repair (Kasprzak, 2002; Barchowsky and O' Hara, 
2003). Therefore, both redox-inactive and redox-active metals may potentially lead to an 
increase in ROS in smokers. Transition metals in the tar of CS have a capacity to 
promote hydroxyl radicals formation both in aqueous extracts of CS and in living tissues 
via the Fenton reaction. Both cuprous ion (Cu+) and ferrous ion (Fe2+) are suggested to 
be active in the formation of hydroxyl radicals as these ions may form complexes with 
many organic molecules which include those that undergo redox cycling (Stohs and 
Bagchi, 1995; Bagchi, 1997). Cupric ion (Cu2+) has been reported to oxidize 
hydroquinone and catechol to their respective quinones. However, ferric ion (Fe3+) does 
not significantly enhance the rate of hydroquinone oxidation (Li et al., 1995; Hirakawa 
et al., 2002). 
 
 CS consists of abundant oxidizing agents that are formed in the gas vapor phase 
(Church and Pryor, 1985; Pyror, 1992). Nitric oxide is a radical which combines slowly 
with molecular oxygen forming toxic oxidant and nitrating agent which is nitrogen 
dioxide. Pryor et al. (1983) reported that nitrogen dioxide reacts immediately with other 
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smoke components which include butadiene and isoprene forming nitroso carbon-
centered radicals which is highly reactive species. The gas phase carbon-centered 
radicals in smoke react rapidly with molecular oxygen forming peroxyl radicals that 
react with smoke gas phase nitric oxide to form nitrogen dioxide and alkoxyl radicals, 
thus, generating a continuous cycle. At physiological concentrations, nitric oxide itself is 
relatively unreactive with non radical molecules (Halliwell and Gutteridge, 1999). 
However, it may react with tyrosyl radical, which is located at the active sites of some 
enzymes namely ribonucleotide reductase (Kwon et al., 1991; Lepoivre et al., 1994). 
Nitric oxide may be converted to more reactive substances known as RNS. Nitration of 
tyrosine and DNA damage in cells exposed to the gas phase of CS has been reported due 
to the action of RNS (Eiserich et al., 1994; Spencer et al., 1995). Nitric oxide is 
demonstrated to enhance the phenolic compounds toxicity by oxidation to their 
respective quinones (Urios et al., 2003). 
 
 The simultaneous reaction between nitric oxide and superoxide may form 
peroxynitrite. Although peroxynitrite is being derived from two free radicals, it is itself 
not a free radical. However, in physiological media, it is a powerful oxidant that has 
been reported to induce damage to essential biomolecules (Halliwell and Gutteridge, 
1999; Denicola and Radi, 2005). Peroxynitrite is known as an oxidative stress-inducing 
compound of aqueous CS fractions (Muller and Gebel, 1994; Muller and Gebel, 1998). 
Peroxynitrite interferes with specific target molecules after depletion of intracellular 
GSH content by electrophilic aldehydes in cigarette smoking-treated cells in vitro which 
results in the activation of stress related signal transduction and gene expression (Muller 
and Gebel, 1994). 
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 The free radicals from components of CS such as superoxide may react with 
nitric oxide causing decrease in nitric oxide bioavaibility (Kojda and Harrison, 1999) 
which subsequently, may lead to endothelial dysfunction. Endothelial dysfunction is a 
major factor in contributing for acute cardiovascular events as well as initiating 
atherogenesis events (Neunteufl et al., 2002). Previous studies have reported that CS 
exposure is associated with a decrease in vasodilatory function in both animal models 
(Ota et al., 1997) and humans (Barua et al., 2001; Ijzerman et al., 2003). In smokers, an 
impairment of arterial vasodilatation appears to be as a result of impaired release of 
endothelium-derived relaxing factor which is suggested to be nitric oxide. Exposure to 
serum of smokers decreases nitric oxide availability from both human coronary artery 
endothelial cells and human umbilical vein endothelial cells by altering the endothelial 
nitric oxide synthase enzyme expression and activity (Higman et al., 1993). Normal 
release of nitric oxide has beneficial cardiovascular role in regulating the adhesion of 
leukocyte to the endothelium, activation of platelet and thrombosis (Napoli and Ignarro, 
2001). Therefore, impairment of nitric oxide release in cigarette smokers may predispose 
to acute cardiovascular events and acceleration of atherogenesis (Puranik and 
Celermajer, 2003).  
 
 On the other hand, nitric oxide may both promote and inhibit lipid peroxidation. 
Nitric oxide by itself acts as a potent lipid peroxidation chain reaction inhibitor by 
scavenging propagatory lipid peroxyl radicals. Furthermore, nitric oxide may inhibit 
potential initiator of lipid peroxidation such as peroxidase enzymes. However, in the 
presence of superoxide, nitric oxide may form peroxynitrite, a strong oxidant which is 
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able to initiate lipid peroxidation as well as oxidize lipid soluble antioxidants (Hogg and 
Kalyanaraman, 1999).  
 
 The prothrombotic effects following CS exposure have been reported to cause 
alterations in platelet function, antithrombotic/prothrombotic factors and fibrinolytic 
factors. Previous studies reported that platelets isolated from smokers demonstrated 
spontaneous aggregation (Rival et al., 1987; Fusegawa et al., 1999). Apart from that, 
platelets isolated from non smokers shows hyperaggregability after exposure to serum of 
smokers (Blache, 1995). CS may decrease the sensitivity of platelet to exogenous nitric 
oxide and decrease the availability of platelet-derived nitric oxide which subsequently, 
causes increased activation and adhesion (Sawada et al., 2002). In addition, several 
studies have also reported the effects of smoking on thrombo-hemostatic factors (tissue 
factor and tissue factor pathway inhibitor). Barua and colleague have reported that serum 
from chronic smokers incubated with human umbilical vein endothelial cells 
significantly decreases tissue factor pathway inhibitor-1 level and relatively increases 
tissue factor level in tissue culture (Barua et al., 2002). Furthermore, an increase in 
activity of circulating tissue factor in smokers has been observed in human plasma 2 
hours folowing smoking two cigarettes (Sambola et al., 2003). In addition, higher 
hematocrits, red blood cell counts, blood viscosity and an ongoing inflammatory 
process, in turn, will enhance the prothrombotic process associated with smoke exposure 
(Glantz and Parmley, 1991; Smith and Fischer, 2001).  
 
 Apart from affecting thrombo-hemostatic factors, CS may also cause alteration in 
fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor-1). 
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Serum of chronic smokers incubated with human umbilical vein endothelial cells shows 
a significant decrease in release of both basal and substance-P-stimulated tissue 
plasminogen activator as well as a significant alteration in tissue plasminogen activator / 
plasminogen activator inhibitor-1 molar ratio (Barua et al., 2002). Furthermore, 
decreased plasma tissue plasminogen activator antigen and activity have been reported 
in samples isolated from brachial and coronary arteries following pharmacologic 
stimulation in smokers (Newby et al., 1999; Pretorius et al., 2002). Thus, smoking 
associated with dysfunctional thrombohemostatic mechanisms may initiate and 
accelerate the atherothrombotic process.The effects of CS on oxidative stress and 
acceleration of atherothrombotic process are summarized in figure 2.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
